11:17 AM EDT, 07/11/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending slightly higher late Thursday morning, rising 0.19% to 1,460.27 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm BioNTech (BNTX) and biopharmaceutical company Genfit ( GNFT ) , which rose 3% and 2.6%, respectively. They were followed by hotel booking site trivago (TRVG) and semiconductor company Sequans Communications ( SQNS ) , which increased 2% each.

The decliners from continental Europe were led by biopharmaceutical company Grifols ( GRFS ) , which declined 1.5%, followed by pharmaceutical firm Novo Nordisk ( NVO ) , which was down 0.9%. Telecommunications company VEON (VEON) and telecommunications operator Nokia ( NOK ) were down 0.7% and 0.6%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and Verona Pharma ( VRNA ) , which advanced 49% and 10%, respectively. They were followed by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) , which climbed 7% and 5.5%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Amarin ( AMRN ) and TC Biopharm ( TCBP ) , which dropped 1.8% and 1.2%, respectively. Telecommunications operator Vodafone Group ( VOD ) and cruise line operator Carnival (CUK) were off 0.8% and 0.5%, respectively.